Phreesia Announces Fiscal Third Quarter 2022 Results

Business Wire2021-12-09

RALEIGH, N.C., December 08, 2021--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) ("Phreesia") announced financial results today for the fiscal third quarter ended October 31, 2021. "We celebrated an ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

飙高音
2021-12-09
飙高音
Great ariticle, would you like to share it?

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2190693269?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-09 07:45","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2190693269","market":"us","top_or_hot":-1,"title":"Phreesia Announces Fiscal Third Quarter 2022 Results","media":"Business Wire","content":"<div>\n<p>RALEIGH, N.C., December 08, 2021--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (\"Phreesia\") announced financial results today for the fiscal third quarter ended October 31, 2021.\n\"We celebrated an ...</p>\n\n<a href=\"https://finance.yahoo.com/news/phreesia-announces-fiscal-third-quarter-210500061.html\">网页链接</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Phreesia Announces Fiscal Third Quarter 2022 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhreesia Announces Fiscal Third Quarter 2022 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-09 07:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/phreesia-announces-fiscal-third-quarter-210500061.html><strong>Business Wire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>RALEIGH, N.C., December 08, 2021--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (\"Phreesia\") announced financial results today for the fiscal third quarter ended October 31, 2021.\n\"We celebrated an ...</p>\n\n<a href=\"https://finance.yahoo.com/news/phreesia-announces-fiscal-third-quarter-210500061.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PHR","symbol_name":"Phreesia, Inc.","start_time":0,"source_url":"https://finance.yahoo.com/news/phreesia-announces-fiscal-third-quarter-210500061.html","article_id":"2190693269","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2190693269","pubTimestamp":1639007129,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"RALEIGH, N.C., December 08, 2021--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (\"Phreesia\") announced","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"PHR":"Phreesia, Inc.","BK4167":"医疗保健技术"},"translate_title":"Phreesia公布2022年第三财季业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"838030":0.9,"838163":0.9,"838275":0.9,"838924":0.9,"PHR":0.9},"content_text":"RALEIGH, N.C., December 08, 2021--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (\"Phreesia\") announced financial results today for the fiscal third quarter ended October 31, 2021.\n\"We celebrated an important milestone in September as we surpassed 100 million patient visits enabled by our platform during the previous twelve months\", said CEO and Co-Founder Chaim Indig. \"Every member of the Phreesia team has contributed to this achievement; I would like to congratulate them on reaching this milestone, and thank our clients for entrusting us to create a better, more engaging healthcare experience\".\nFiscal Third Quarter 2022 Highlights\n\nRevenue was $55.9 million in the quarter as compared to $38.5 million in the same period in the prior year, an increase of 45%.\n\n\nAverage number of provider clients was 2,097 in the quarter as compared to 1,737 in the same period in the prior year, an increase of 21%.\n\n\nAverage revenue per provider client was $19,299 in the quarter compared to $17,490 in the same period in the prior year, an increase of 10%.\n\n\nAdjusted EBITDA was negative $17.6 million in the quarter compared to positive $1.2 million in the same period in the prior year, reflecting increased growth investment.\n\n\nCash and cash equivalents as of October 31, 2021 was $400.4 million, an increase of $181.6 million compared to January 31, 2021, driven primarily by our follow-on offering of common stock, which generated net proceeds of $245.8 million, partially offset by cash used for operating activities, capital expenditures and payments of finance leases and other debt.\n\nOutlook for Fiscal 2022\nWe are increasing our revenue outlook for Fiscal Year 2022 to $211 million from our previously announced range of $195 million to $198 million. Our Adjusted EBITDA outlook for Fiscal Year 2022 is negative $64 million. We expect revenue for Fiscal Year 2023 to grow in the range of 20 to 25% above Fiscal Year 2022 revenue. We also anticipate a continued acceleration in investments in Fiscal Year 2023 from Fiscal Year 2022 levels and will provide an outlook for Adjusted EBITDA for Fiscal Year 2023 when we release our full Fiscal Year 2022 results in March 2022.\nStakeholder Letter and Conference Call Information\nFor additional information about our quarterly results, please refer to our Quarterly Stakeholder Letter that was furnished with our Form 8-K, which was filed with the SEC and can be found at https://ir.phreesia.com/resources/quarterly-stakeholder-letter/default.aspx. The Company will hold a conference call on Thursday, December 9, 2021, at 8:45 a.m. Eastern Time to review the Company’s third fiscal quarter financial results. To participate in the Company’s live conference call and webcast, please dial (866) 211-4557 (or (647) 689-6750 for international participants) using conference code number 7489917 or visit the \"Events & Presentations\" section of ir.phreesia.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.\nRecent Events\nAddition of Insignia Health, LLC to Phreesia\nOn December 3, 2021, Phreesia entered into an agreement to acquire Insignia Health, LLC, a founder-led and mission-oriented company, for $35 million in cash, subject to customary purchase price adjustments. We acquired the company from its founders, the University of Oregon and its other holders of membership interest. We have closely followed Insignia for several years, and long admired the company's background in academic research and its commitment to improving health outcomes through an extensively validated approach to helping patients become more active and successful managers of their health.\nCOVID-19\nIn March 2020, the World Health Organization declared the ongoing outbreak of a novel strain of coronavirus (\"COVID-19\") a pandemic. There continues to be uncertainty as to the duration and extent to which the global COVID-19 pandemic, as well as the emergence of new variants, may adversely impact the Company's business operations, financial performance, and results of operations, as well as macroeconomic conditions, at this time.\n\n\n\n\n\n\nPhreesia, Inc.Consolidated Balance Sheets(in thousands, except share and per share data)\n\n\n\n\n\n\n\n\n\nOctober 31, 2021\n\nJanuary 31, 2021\n\n\n\n(Unaudited)\n\n\n\n\nAssets\n\n\n\n\n\nCurrent:\n\n\n\n\n\nCash and cash equivalents\n$\n400,395\n\n\n$\n218,781\n\n\n\nSettlement assets\n16,323\n\n\n15,488\n\n\n\nAccounts receivable, net of allowance for doubtful accounts of $705 and $699 as of October 31, 2021 and January 31, 2021, respectively\n35,460\n\n\n29,052\n\n\n\nDeferred contract acquisition costs\n1,705\n\n\n1,693\n\n\n\nPrepaid expenses and other current assets\n10,450\n\n\n7,254\n\n\n\nTotal current assets\n464,333\n\n\n272,268\n\n\n\nProperty and equipment, net of accumulated depreciation and amortization of $50,838 and $40,148 as of October 31, 2021 and January 31, 2021, respectively\n32,755\n\n\n26,660\n\n\n\nCapitalized internal-use software, net of accumulated amortization of $29,838 and $25,476 as of October 31, 2021 and January 31, 2021, respectively\n14,079\n\n\n10,476\n\n\n\nOperating lease right-of-use assets\n2,005\n\n\n2,654\n\n\n\nDeferred contract acquisition costs\n2,456\n\n\n1,248\n\n\n\nIntangible assets, net of accumulated amortization of $907 and $525 as of October 31, 2021 and January 31, 2021, respectively\n2,343\n\n\n2,725\n\n\n\nDeferred tax asset\n150\n\n\n658\n\n\n\nGoodwill\n8,211\n\n\n8,307\n\n\n\nOther assets\n2,795\n\n\n1,670\n\n\n\nTotal assets\n$\n529,127\n\n\n$\n326,666\n\n\n\nLiabilities and Stockholders’ Equity\n\n\n\n\n\nCurrent:\n\n\n\n\n\nSettlement obligations\n$\n16,323\n\n\n$\n15,488\n\n\n\nCurrent portion of finance lease liabilities and other debt\n4,597\n\n\n4,864\n\n\n\nCurrent portion of operating lease liabilities\n1,116\n\n\n1,087\n\n\n\nAccounts payable\n11,602\n\n\n4,389\n\n\n\nAccrued expenses\n18,885\n\n\n18,324\n\n\n\nDeferred revenue\n12,434\n\n\n10,838\n\n\n\nTotal current liabilities\n64,957\n\n\n54,990\n\n\n\nLong-term finance lease liabilities and other debt\n5,134\n\n\n6,471\n\n\n\nOperating lease liabilities, non-current\n1,117\n\n\n1,899\n\n\n\nTotal liabilities\n71,208\n\n\n63,360\n\n\n\nCommitments and contingencies\n\n\n\n\n\nStockholders’ Equity:\n\n\n\n\n\nCommon stock, $0.01 par value - 500,000,000 shares authorized as of both October 31, 2021 and January 31, 2021; 51,289,020 and 44,880,883 shares issued as of October 31, 2021 and January 31, 2021, respectively\n513\n\n\n449\n\n\n\nAdditional paid-in capital\n849,450\n\n\n579,599\n\n\n\nAccumulated deficit\n(383,487)\n\n\n(311,777)\n\n\n\nTreasury stock, at cost, 157,612 and 99,520 shares at October 31, 2021 and January 31, 2021, respectively\n(8,557)\n\n\n(4,965)\n\n\n\nTotal Stockholders’ Equity\n457,919\n\n\n263,306\n\n\n\nTotal Liabilities and Stockholders’ Equity\n$\n529,127\n\n\n$\n326,666\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPhreesia, Inc.Consolidated Statements of Operations(Unaudited)(in thousands, except share and per share data)\n\n\n\n\n\n\n\n\n\nThree months ended October 31,\n\nNine months ended October 31,\n\n\n\n2021\n\n2020\n\n2021\n\n2020\n\n\nRevenue:\n\n\n\n\n\n\n\n\n\nSubscription and related services\n$\n24,365\n\n\n$\n17,468\n\n\n$\n69,069\n\n\n$\n50,196\n\n\n\nPayment processing fees\n16,111\n\n\n12,917\n\n\n49,061\n\n\n36,452\n\n\n\nLife sciences\n15,439\n\n\n8,079\n\n\n37,083\n\n\n20,221\n\n\n\nTotal revenues\n55,915\n\n\n38,464\n\n\n155,213\n\n\n106,869\n\n\n\nExpenses:\n\n\n\n\n\n\n\n\n\nCost of revenue (excluding depreciation and amortization)\n11,644\n\n\n6,472\n\n\n30,210\n\n\n16,477\n\n\n\nPayment processing expense\n9,449\n\n\n7,530\n\n\n28,822\n\n\n21,125\n\n\n\nSales and marketing\n32,036\n\n\n10,481\n\n\n69,215\n\n\n30,013\n\n\n\nResearch and development\n15,273\n\n\n5,732\n\n\n34,770\n\n\n16,267\n\n\n\nGeneral and administrative\n18,021\n\n\n10,370\n\n\n46,936\n\n\n28,721\n\n\n\nDepreciation\n3,719\n\n\n2,447\n\n\n10,717\n\n\n7,125\n\n\n\nAmortization\n1,513\n\n\n1,546\n\n\n4,744\n\n\n4,531\n\n\n\nTotal expenses\n91,655\n\n\n44,578\n\n\n225,414\n\n\n124,259\n\n\n\nOperating loss\n(35,740)\n\n\n(6,114)\n\n\n(70,201)\n\n\n(17,390)\n\n\n\nOther (expense) income, net\n(114)\n\n\n62\n\n\n(138)\n\n\n(229)\n\n\n\nInterest (expense) income, net\n(311)\n\n\n(467)\n\n\n(756)\n\n\n(1,206)\n\n\n\nTotal other expense, net\n(425)\n\n\n(405)\n\n\n(894)\n\n\n(1,435)\n\n\n\nLoss before provision for income taxes\n(36,165)\n\n\n(6,519)\n\n\n(71,095)\n\n\n(18,825)\n\n\n\nProvision for income taxes\n(178)\n\n\n(194)\n\n\n(615)\n\n\n(371)\n\n\n\nNet loss\n$\n(36,343)\n\n\n$\n(6,713)\n\n\n$\n(71,710)\n\n\n$\n(19,196)\n\n\n\nNet loss per share attributable to common stockholders, basic and diluted\n$\n(0.71)\n\n\n$\n(0.17)\n\n\n$\n(1.44)\n\n\n$\n(0.51)\n\n\n\nWeighted-average common shares outstanding, basic and diluted\n51,020,271\n\n\n38,511,370\n\n\n49,943,049\n\n\n37,855,503\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPhreesia, Inc.Unaudited Consolidated Statements of Cash Flows(in thousands)\n\n\n\n\n\n\n\n\n\n\nNine months Ended October 31,\n\n\n\n\n2021\n\n2020\n\n\nOperating activities:\n\n\n\n\n\n\nNet loss\n\n$\n(71,710)\n\n\n$\n(19,196)\n\n\n\nAdjustments to reconcile net loss to net cash used in operating activities:\n\n\n\n\n\n\nDepreciation and amortization\n\n15,461\n\n\n11,656\n\n\n\nStock-based compensation expense\n\n25,976\n\n\n9,616\n\n\n\nAmortization of deferred financing costs and debt discount\n\n216\n\n\n318\n\n\n\nCost of Phreesia hardware purchased by customers\n\n449\n\n\n604\n\n\n\nDeferred contract acquisition costs amortization\n\n1,709\n\n\n2,280\n\n\n\nNon-cash operating lease expense\n730\n\n\n1,228\n\n\n\nChange in fair value of contingent consideration liabilities\n\n209\n\n\n—\n\n\n\nDeferred tax asset\n\n508\n\n\n279\n\n\n\nChanges in operating assets and liabilities:\n\n\n\n\n\n\nAccounts receivable\n\n(6,408)\n\n\n(5,616)\n\n\n\nPrepaid expenses and other assets\n\n(5,686)\n\n\n(1,940)\n\n\n\nDeferred contract acquisition costs\n\n(2,929)\n\n\n(1,901)\n\n\n\nAccounts payable\n\n9,490\n\n\n(2,300)\n\n\n\nAccrued expenses and other liabilities\n\n(5,563)\n\n\n3,982\n\n\n\nLease liability\n\n(779)\n\n\n(1,419)\n\n\n\nDeferred revenue\n\n1,596\n\n\n1,222\n\n\n\nNet cash used in operating activities\n\n(36,731)\n\n\n(1,187)\n\n\n\nInvesting activities:\n\n\n\n\n\n\nCapitalized internal-use software\n\n(7,962)\n\n\n(4,663)\n\n\n\nPurchase of property and equipment\n\n(16,596)\n\n\n(6,440)\n\n\n\nNet cash used in investing activities\n\n(24,558)\n\n\n(11,103)\n\n\n\nFinancing activities:\n\n\n\n\n\n\nProceeds from issuance of common stock in equity offerings, net of underwriters' discounts and commissions\n\n245,813\n\n\n174,800\n\n\n\nProceeds from issuance of common stock upon exercise of stock options\n\n4,062\n\n\n3,351\n\n\n\nTreasury stock to satisfy tax withholdings on stock compensation awards\n\n(3,546)\n\n\n(869)\n\n\n\nPayment of offering costs\n\n—\n\n\n(226)\n\n\n\nProceeds from employee stock purchase plan\n\n1,147\n\n\n—\n\n\n\nInsurance financing agreement\n\n—\n\n\n2,009\n\n\n\nFinance lease payments\n\n(3,175)\n\n\n(1,797)\n\n\n\nPrincipal payments on financing agreements\n\n(873)\n\n\n(881)\n\n\n\nDebt issuance costs\n\n—\n\n\n(69)\n\n\n\nLoan facility fee payment\n\n(125)\n\n\n(225)\n\n\n\nPayment of contingent consideration for acquisitions\n\n(400)\n\n\n—\n\n\n\nNet cash provided by financing activities\n\n242,903\n\n\n176,093\n\n\n\nNet increase in cash and cash equivalents\n\n181,614\n\n\n163,803\n\n\n\nCash and cash equivalents – beginning of period\n\n218,781\n\n\n90,315\n\n\n\nCash and cash equivalents – end of period\n\n$\n400,395\n\n\n$\n254,118\n\n\n\n\n\n\n\n\n\n\nSupplemental information of non-cash investing and financing information:\n\n\n\n\n\n\nRight-of-use assets obtained in exchange for operating lease liabilities\n\n$\n81\n\n\n$\n4,420\n\n\n\nProperty and equipment acquisitions through finance leases\n\n$\n2,645\n\n\n$\n6,050\n\n\n\nCapitalized software acquired through vendor financing\n\n$\n—\n\n\n$\n174\n\n\n\nCashless transfer of term loan and related accrued fees into increase in debt balance\n\n$\n—\n\n\n$\n20,257\n\n\n\nCashless transfer of lender fees through increase in debt balance\n\n$\n—\n\n\n$\n406\n\n\n\nDeferred offering costs included in accounts payable and accrued liabilities\n\n$\n—\n\n\n$\n64\n\n\n\nPurchase of property and equipment and capitalized software included in accounts payable\n\n$\n1,082\n\n\n$\n1,681\n\n\n\nCapitalized stock-based compensation\n\n$\n279\n\n\n$\n—\n\n\n\nCash payments for:\n\n\n\n\n\n\nInterest\n\n$\n578\n\n\n$\n1,047\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNon-GAAP financial measures\nAdjusted EBITDA is a supplemental measure of our performance that is not required by, or presented in accordance with, GAAP. Adjusted EBITDA is not a measurement of our financial performance under GAAP and should not be considered as an alternative to net income or loss or any other performance measure derived in accordance with GAAP, or as an alternative to cash flows from operating activities as a measure of our liquidity. We define Adjusted EBITDA as net income or loss before interest expense (income), net, provision for income taxes, depreciation and amortization, and before stock-based compensation expense, change in fair value of contingent consideration liabilities and other expense (income), net.\nWe have provided below a reconciliation of Adjusted EBITDA to net loss, the most directly comparable GAAP financial measure. We have presented Adjusted EBITDA in this press release and our Annual Report on Form 10-K because it is a key measure used by our management and board of directors to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget, and to develop short and long-term operational plans. In particular, we believe that the exclusion of the amounts eliminated in calculating Adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core business. Accordingly, we believe that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors. Phreesia has not reconciled its Adjusted EBITDA outlook to GAAP Net income (loss) because it does not provide an outlook for GAAP Net income (loss) due to the uncertainty and potential variability of Other income, net and Provision for (benefit from) income taxes, which are reconciling items between Adjusted EBITDA and GAAP Net income (loss). Because Phreesia cannot reasonably predict such items, a reconciliation of the non-GAAP financial measure outlook to the corresponding GAAP measure is not available without unreasonable effort. We caution, however, that such items could have a significant impact on the calculation of GAAP Net income (loss).\nOur use of Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our financial results as reported under GAAP. Some of these limitations are as follows:\n\nAlthough depreciation and amortization expense are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;\n\n\nAdjusted EBITDA does not reflect: (1) changes in, or cash requirements for, our working capital needs; (2) the potentially dilutive impact of non-cash stock-based compensation; (3) tax payments that may represent a reduction in cash available to us; or (4) Interest expense (income), net; and\n\n\nOther companies, including companies in our industry, may calculate Adjusted EBITDA or similarly titled measures differently, which reduces its usefulness as a comparative measure.\n\nBecause of these and other limitations, you should consider Adjusted EBITDA along with other GAAP-based financial performance measures, including various cash flow metrics, net loss, and our GAAP financial results. The following table presents a reconciliation of Adjusted EBITDA to net loss for each of the periods indicated:\n\n\n\n\n\n\nPhreesia, Inc.Adjusted EBITDA(Unaudited)\n\n\n\n\n\n\n\n\n\n\nThree months ended October 31,\n\nNine months ended October 31,\n\n\n(in thousands)\n\n2021\n\n2020\n\n2021\n\n2020\n\n\nNet loss\n\n$\n(36,343)\n\n\n$\n(6,713)\n\n\n$\n(71,710)\n\n\n$\n(19,196)\n\n\n\nInterest expense (income), net\n\n311\n\n\n467\n\n\n756\n\n\n1,206\n\n\n\nProvision for income taxes\n\n178\n\n\n194\n\n\n615\n\n\n371\n\n\n\nDepreciation and amortization\n\n5,232\n\n\n3,993\n\n\n15,461\n\n\n11,656\n\n\n\nStock-based compensation expense\n\n12,929\n\n\n3,316\n\n\n25,976\n\n\n9,616\n\n\n\nChange in fair value of contingent consideration liabilities\n\n—\n\n\n—\n\n\n209\n\n\n—\n\n\n\nOther expense (income), net\n\n114\n\n\n(62)\n\n\n138\n\n\n229\n\n\n\nAdjusted EBITDA\n\n$\n(17,579)\n\n\n$\n1,195\n\n\n$\n(28,555)\n\n\n$\n3,882\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPhreesia, Inc.Reconciliation of GAAP and Adjusted Operating Expenses(Unaudited)\n\n\n\n\n\n\n\n\n\n\nThree months ended October 31,\n\nNine months ended October 31,\n\n\n(in thousands)\n\n2021\n\n2020\n\n2021\n\n2020\n\n\nGAAP operating expenses\n\n\n\n\n\n\n\n\n\n\nGeneral and administrative\n\n$\n18,021\n\n\n$\n10,370\n\n\n$\n46,936\n\n\n$\n28,721\n\n\n\nSales and marketing\n\n32,036\n\n\n10,481\n\n\n69,215\n\n\n30,013\n\n\n\nResearch and development\n\n15,273\n\n\n5,732\n\n\n34,770\n\n\n16,267\n\n\n\nCost of revenue\n\n11,644\n\n\n6,472\n\n\n30,210\n\n\n16,477\n\n\n\n\n\n$\n76,974\n\n\n$\n33,055\n\n\n$\n181,131\n\n\n$\n91,478\n\n\n\nStock compensation included in GAAP operating expenses\n\n\n\n\n\n\n\n\n\n\nGeneral and administrative\n\n$\n4,943\n\n\n1,635\n\n\n$\n11,237\n\n\n$\n5,169\n\n\n\nSales and marketing\n\n5,169\n\n\n1,008\n\n\n9,046\n\n\n2,530\n\n\n\nResearch and development\n\n2,224\n\n\n470\n\n\n4,212\n\n\n1,494\n\n\n\nCost of revenue\n\n593\n\n\n203\n\n\n$\n1,481\n\n\n$\n423\n\n\n\n\n\n$\n12,929\n\n\n$\n3,316\n\n\n$\n25,976\n\n\n$\n9,616\n\n\n\nAdjusted operating expenses\n\n\n\n\n\n\n\n\n\n\nGeneral and administrative\n\n$\n13,078\n\n\n$\n8,735\n\n\n$\n35,699\n\n\n$\n23,552\n\n\n\nSales and marketing\n\n26,867\n\n\n9,473\n\n\n60,169\n\n\n27,483\n\n\n\nResearch and development\n\n13,049\n\n\n5,262\n\n\n30,558\n\n\n14,773\n\n\n\nCost of revenue\n\n11,051\n\n\n6,269\n\n\n28,729\n\n\n16,054\n\n\n\n\n\n$\n64,045\n\n\n$\n29,739\n\n\n$\n155,155\n\n\n$\n81,862\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPhreesia, Inc.Key Metrics(Unaudited)\n\n\n\n\n\n\n\n\n\n\nThree months ended October 31,\n\nNine months ended October 31,\n\n\n\n\n2021\n\n2020\n\n2021\n\n2020\n\n\nKey Metrics:\n\n\n\n\n\n\n\n\n\n\nProvider clients (average over period)\n\n2,097\n\n\n1,737\n\n\n1,996\n\n\n1,679\n\n\n\nAverage revenue per provider client\n\n$\n19,299\n\n\n$\n17,490\n\n\n$\n59,196\n\n\n$\n51,604\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nProvider clients. We define provider clients as the average number of healthcare provider organizations that generate revenue each month during the applicable period. In cases where we act as a subcontractor providing white-label services to our partner's clients, we treat the contractual relationship as a single provider client. We believe growth in the number of provider clients is a key indicator of the performance of our business and depends, in part, on our ability to successfully develop and market our Platform to healthcare provider organizations that are not yet clients. While growth in the number of provider clients is an important indicator of expected revenue growth, it also informs our management of the areas of our business that will require further investment to support expected future provider client growth. For example, as the number of provider clients increases, we may need to add to our customer support team and invest to maintain effectiveness and performance of our Platform and software for our provider clients and their patients.\n\n\nAverage revenue per provider client.We define average revenue per provider client as the total subscription and related services and payment processing revenue generated from provider clients in a given period divided by the average number of provider clients that generate revenue each month during that same period. We are focused on continually delivering value to our provider clients and believe that our ability to increase average revenue per provider client is an indicator of the long-term value of the Phreesia platform.\n\n\n\n\n\n\n\nAdditional Information(Unaudited)\n\n\n\n\n\n\n\n\n\n\nThree months endedOctober 31,\nNine months ended October 31,\n\n\n\n\n2021\n\n2020\n2021\n\n2020\n\n\nPatient payment volume (in millions)\n\n$\n682\n\n\n$\n524\n\n$\n2,079\n\n\n$\n1,445\n\n\n\nPayment facilitator volume percentage\n\n79\n%\n\n80\n%\n78\n%\n\n82\n%\n\n\n\n\nPatient payment volume. We believe that patient payment volume is an indicator of both the underlying health of our provider clients’ businesses and the continuing shift of healthcare costs to patients. We measure patient payment volume as the total dollar volume of transactions between our provider clients and their patients utilizing our payment platform, including via credit and debit cards that we process as a payment facilitator as well as cash and check payments and credit and debit transactions for which Phreesia acts as a gateway to other payment processors.\n\n\nPayment facilitator volume percentage. We define payment facilitator volume percentage as the volume of credit and debit card patient payment volume that we process as a payment facilitator as a percentage of total patient payment volume. Payment facilitator volume is a major driver of our payment processing revenue.\n\n\n\nAvailable Information\nPhreesia intends to use its Company website (including its Investor Relations website) as well as its Facebook, Twitter and LinkedIn accounts as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.\nForward Looking Statements\nThis press release includes forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended that involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance and may contain projections of our future results of operations or of our financial information or state other forward-looking information. In some cases, you can identify forward-looking statements by the following words: \"may,\" \"will,\" \"could,\" \"would,\" \"should,\" \"expect,\" \"intend,\" \"plan,\" \"anticipate,\" \"believe,\" \"estimate,\" \"predict,\" \"project,\" \"potential,\" \"continue,\" \"ongoing,\" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward looking statements. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control, including, without limitation, statements about our future financial performance, including our revenue, cash flows, costs of revenue and operating expenses; our anticipated growth; our predictions about our industry; the impact of the COVID-19 pandemic on our business and our ability to attract, retain and cross-sell to healthcare provider clients; and our ability to realize the intended benefits of our acquisitions. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including those more fully described in our filings with the Securities and Exchange Commission (\"SEC\"), including in our Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2021 that will be filed with the SEC following this press release. The forward-looking statements in this press release speak only as of the date on which the statements are made. We undertake no obligation to update, and expressly disclaim the obligation to update, any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements.\nThis press release includes certain non-GAAP financial measures as defined by SEC rules. We have provided a reconciliation of those measures to the most directly comparable GAAP measures.\nABOUT PHREESIA\nPhreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20211208006051/en/\nContacts\nInvestors:\nBalaji Gandhi\nPhreesia, Inc.\ninvestors@phreesia.com\n(929) 506-4950\n\nMedia:\nAnnie Harris\nPhreesia, Inc.\naharris@phreesia.com\n(929) 526-2611","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":602882211,"gmtCreate":1639007309236,"gmtModify":1639007309571,"author":{"id":"3582709856792743","authorId":"3582709856792743","name":"飙高音","avatar":"https://static.tigerbbs.com/475b76d560816b91289272c06ae8dfff","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602882211","repostId":2190693269,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":49,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2190693269"}